64
Participants
Start Date
May 27, 2021
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2024
MT-6402
Experimental Treatment
Pennsylvania Cancer Specialists and Research Institute, Gettysburg
Carolina BioOncology, Huntersville
Prisma Health, Greenville
Comprehensive Care and Research Center - Atlanta, Newnan
Tennessee Oncology, PLLC, Nashville
University of Louisville Health - Brown Cancer Center, Louisville
Sanford Cancer Center, Sioux Falls
Comprehensive Care and Research Center - Chicago, Chicago
Washington University School of Medicine - St. Louis, St Louis
Mary Crowley Cancer Research, Dallas
Oncology Consultants, Houston
South Texas Accelerated Research Therapeutics, LLC, San Antonio
USC Medical Center, Los Angeles
Cedars Sinai Medical Center, Los Angeles
City of Hope Medical Center, Duarte
Dartmouth Hitchcock, Lebanon
Lead Sponsor
Molecular Templates, Inc.
INDUSTRY